An Investigational New Drug (IND) is a drug or biological drug that has not been approved for general use by the FDA. It is used in a clinical trial to investigate its safety and efficacy. The term ...

The last decade has seen a “dramatic increase” in investigational new drug (IND) applications for ... “Nearly identical to the number of applications received in the past 10 years.” ...

The IDS at UMHS requires that investigational and study drugs be ordered on these forms. The medication order forms are tailored to each study, identified by the study title and protocol number ...

Please provide your email address to receive an email when new articles ... impacts the number of apnea-hypopnea episodes and nighttime blood pressure (BP). The drug’s safety profile in this ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

The U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for MF-300, a first-in-class orally administered, 15-hydroxyprostaglandin ...

The good news is that Investigational New Drug submissions and New Drug Applications continue to be above average, with the latter hitting a high not seen since 1999.

Principal Investigators on treatment protocols that involve an Investigational New Drug (IND) must complete Form FDA 1572 ... or biologics (i.e., agents that require an IND application/number for ...